STOCK TITAN

Abacus Global Management Stock Price, News & Analysis

ABLLW Nasdaq

Welcome to our dedicated page for Abacus Global Management news (Ticker: ABLLW), a resource for investors and traders seeking the latest updates and insights on Abacus Global Management stock.

The ABLLW news page on Stock Titan provides historical coverage related to the public warrants of Abacus Global Management, Inc. and the Company’s broader activities in alternative asset management and financial services. ABLLW identified warrants listed on The Nasdaq Stock Market LLC that were exercisable for Abacus common stock, and many Company announcements referenced these warrants alongside common stock and senior notes.

News items associated with ABLLW include Abacus’s communications about its exchange offer and consent solicitation for public and private placement warrants, where the Company offered shares of common stock in exchange for outstanding warrants. Subsequent updates describe the completion of the offer, the post-offer exchange, and the resulting decision that no warrants would remain outstanding. Regulatory milestones, such as the expected suspension and delisting of the public warrants, are reflected in Company press releases and SEC filings.

Beyond warrant-specific developments, the ABLLW-linked news flow also touches on Abacus’s evolution as an alternative asset manager. Articles cover topics such as the Company’s focus on longevity-based assets, the growth of its longevity funds, the launch of an asset-based finance strategy within Abacus Asset Group, and the completion of a securitized note backed by life insurance assets. Other releases highlight strategic acquisitions like AccuQuote, capital allocation decisions including an annual dividend and share repurchase program, and the transfer of the Company’s common stock listing from Nasdaq to the New York Stock Exchange under a new ticker.

Investors and researchers can use this news archive to understand how Abacus managed its warrant capital structure under the ABLLW symbol, how those warrants were ultimately exchanged and delisted, and how these steps fit within the Company’s broader strategy in alternative asset management, insurance-related assets, securitized products, and wealth solutions.

Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL) has successfully completed its warrant exchange offer and consent solicitation. The company received tenders for 18,188,277 warrants, representing approximately 88% of outstanding warrants, before the offer's expiration on July 29, 2025.

The consent solicitation garnered approval from 83% of public warrant holders and 94% of private placement warrant holders to amend the warrant agreement, surpassing the required 50% threshold. Following this success, Abacus will exchange remaining warrants at a ratio of 0.207 shares of common stock per warrant, which is 10% less than the original exchange offer ratio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.08%
Tags
none
-
Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL), an alternative asset management company, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.

The company will host a conference call at 5:00 PM ET on the same day to discuss the results. Investors can access the call through a toll-free number (844) 826-3033 or international number (412) 317-5185. A live webcast will be available on the company's investor relations website, with a replay accessible for one year following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.9%
Tags
-
Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL), a leader in alternative asset management, has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger for defamation and anticompetitive conduct in Florida's Ninth Circuit Court. The lawsuit alleges that Coventry and Buerger orchestrated a systematic campaign to spread false information about Abacus's valuation practices, culminating in a short report by Morpheus Research on June 4, 2025.

The legal action details how Coventry's campaign led to a 21% drop in Abacus's stock price, erasing over $200 million in market capitalization. Abacus claims Coventry spread misleading information to regulators, auditors, analysts, and investors, particularly regarding Abacus's use of Lapetus Solutions for life expectancy estimates.

Abacus CEO Jay Jackson emphasizes that the company's transparent pricing model has been validated by market transactions, with policies consistently selling to sophisticated investors like KKR at prices exceeding Abacus's valuations. The company is seeking hundreds of millions in damages for harm to its reputation, customer base, and investor relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
none
Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL) has launched an exchange offer and consent solicitation for its outstanding public and private placement warrants. The company is offering 0.23 shares of common stock for each warrant tendered, with a total offering of up to 4,743,381 shares of common stock in exchange.

The exchange offer will run until July 29, 2025. Concurrently, Abacus is seeking consent to amend the warrant agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% reduction from the current offer ratio. Currently, parties representing 25% of public warrants and 94% of private placement warrants have agreed to the exchange.

As of June 30, 2025, Abacus has 97,867,821 shares of common stock outstanding and 20,623,395 total warrants. If all warrant holders participate, the company would issue approximately 4.7 million new shares, increasing the total outstanding shares by about 5% to 102,611,202.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.89%
Tags
none
-
Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL) has announced plans to conduct an exchange offer and consent solicitation for its outstanding warrants. The company is offering 0.23 shares of common stock for each warrant tendered in the exchange. Additionally, ABL is seeking consent to amend the Warrant Agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% lower ratio than the initial offer.

Currently, each warrant allows holders to purchase one common share at $11.50 per share. The amendment would require approval from at least 50% of public warrant holders. The exchange offer will commence following the filing of a Form S-4 registration statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.14%
Tags
none
-
Rhea-AI Summary
Abacus Global Management (NASDAQ: ABL) launched a new corporate commercial campaign at their Investor Day and Longevity Summit at Nasdaq in NYC on June 12th, 2025. The campaign positions Abacus as a leader in longevity-based asset management, featuring CEO Jay Jackson highlighting the company's mission to revolutionize financial planning by incorporating lifespan data. The commercial, now airing nationally, emphasizes Abacus's proprietary longevity data and their unique position in providing longevity-based financial solutions to clients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.21%
Tags
none
Rhea-AI Summary
Abacus Global Management (NASDAQ: ABL) has strongly refuted recent short seller claims regarding its balance sheet valuation practices. The company provided evidence through an independent third-party actuarial validation by Lewis and Ellis, which confirmed their Q1 2025 life settlement portfolio valuation of $449 million, aligning within 1% of Abacus's stated $446 million valuation. Multiple analysts maintain positive ratings with price targets ranging from $12-$15. The company clarified its dual valuation approach: using life expectancy estimates for consumer transactions while employing market-based valuations for portfolio management. Recent Q2 sales of 226 policies for $141.4 million validated their mark-to-market approach, generating a 1.65% gain over their March 31 valuations. Management, owning 46% of shares, faces a lock-up expiration in July 2025, with anticipated inclusion in Russell 2000 and 3000 indices in August 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.26%
Tags
none
-
Rhea-AI Summary
Abacus Global Management (NASDAQ: ABL) has announced a new $20 million share repurchase program effective June 5, 2025, extending over 18 months. The announcement comes amid a short attack on the company, with CEO Jay Jackson stating that the current share price is artificially depressed. The company's employees have demonstrated confidence by purchasing over $2 million worth of shares. The repurchase program allows the company to buy shares through various methods including open market transactions and block trades. The timing and value of repurchases will be determined based on factors such as stock price, market conditions, and available liquidity. The program will be funded through cash on hand and future free cash flow. Abacus maintains its 20-year track record of generating positive revenue and plans to pursue legal action against those responsible for the short attack.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12%
Tags
buybacks
-
Rhea-AI Summary
Abacus Global Management (NASDAQ: ABL) has issued a strong rebuttal to a short seller's report, defending its 20-year track record in the life insurance policy trading business. The company reported Q1 2025 realized gains of nearly 40% on $126 million deployed capital, with valuations within 2% margin of error from the previous quarter. CEO Jay Jackson emphasized that Abacus's returns and valuations are audited, suggesting the short report was orchestrated by their largest competitor. As the only publicly traded company in its category, Abacus highlighted its high regulatory oversight across multiple states. The company plans to provide a detailed response to the short seller's claims and pursue legal action against those responsible for the allegedly false and misleading attack.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-39.99%
Tags
none
Rhea-AI Summary

Abacus Global Management (NASDAQ: ABL) has announced the details for its upcoming virtual Abacus Investor Day and Longevity Summit, scheduled for Thursday, June 12th, 2025. The event will run from 9:30 AM ET to 12:45 PM ET and will be accessible via livestream.

This specialized one-day event will focus on integrating lifespan considerations into financial products. The summit will feature presentations on the company's business model, current ABL products, and future outlook. Additionally, leading experts in longevity and lifespan will discuss how human longevity impacts financial planning strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.93%
Tags
none

FAQ

What is the current stock price of Abacus Global Management (ABLLW)?

The current stock price of Abacus Global Management (ABLLW) is $1.2913 as of August 13, 2025.

ABLLW Rankings

ABLLW Stock Data

27.48M
Insurance Agencies and Brokerages
Investment Advice
ORLANDO

ABLLW RSS Feed